Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Dow
Johnson and Johnson
Colorcon
AstraZeneca

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR COLISTIN SULFATE

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for colistin sulfate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02472600 ↗ Eradication of Antibiotic-resistant Bacteria Through Antibiotics and Fecal Bacteriotherapy Unknown status European Commission Phase 2 2016-02-01 This investigator initiated,international, multicenter open-label, randomized controlled trial aims to assess whether a 5 day course of oral nonabsorbable antibiotics (colistin sulfate 2 million IU per os 4x/day and neomycin sulfate 500 mg (salt) per os 4x/day ) followed by fecal microbiota transplantation (administered either via nasogastric administration or via capsules) is effective at eradicating intestinal carriage of beta-lactamase producing Enterobacteriaceae (ESBL-E) and carbapenemase producing Enterobacteriaceae (CPE). compared to no intervention (current standard of care) in adult non-immunosuppressed patients .
NCT02472600 ↗ Eradication of Antibiotic-resistant Bacteria Through Antibiotics and Fecal Bacteriotherapy Unknown status Stephen Harbarth Phase 2 2016-02-01 This investigator initiated,international, multicenter open-label, randomized controlled trial aims to assess whether a 5 day course of oral nonabsorbable antibiotics (colistin sulfate 2 million IU per os 4x/day and neomycin sulfate 500 mg (salt) per os 4x/day ) followed by fecal microbiota transplantation (administered either via nasogastric administration or via capsules) is effective at eradicating intestinal carriage of beta-lactamase producing Enterobacteriaceae (ESBL-E) and carbapenemase producing Enterobacteriaceae (CPE). compared to no intervention (current standard of care) in adult non-immunosuppressed patients .
NCT02482961 ↗ Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection Completed DongGuk University 2015-05-01 This study purposed to examine the adequate range of therapeutic concentration for Korean people by observing curative effects, side effects, blood concentration, etc. in treating CRAB-infected patients with colistin.
NCT02694393 ↗ Inhaled Sodium Nitrite as an Antimicrobial for Cystic Fibrosis Active, not recruiting Cystic Fibrosis Foundation Phase 1/Phase 2 2016-02-01 This study will assess the safety of inhaled sodium nitrite in adults with Cystic Fibrosis and chronic Pseudomonas infections, and determine the ability of sodium nitrite to reduce the burden of Pseudomonas.
NCT02694393 ↗ Inhaled Sodium Nitrite as an Antimicrobial for Cystic Fibrosis Active, not recruiting Cystic Fibrosis Foundation Therapeutics Phase 1/Phase 2 2016-02-01 This study will assess the safety of inhaled sodium nitrite in adults with Cystic Fibrosis and chronic Pseudomonas infections, and determine the ability of sodium nitrite to reduce the burden of Pseudomonas.
NCT02694393 ↗ Inhaled Sodium Nitrite as an Antimicrobial for Cystic Fibrosis Active, not recruiting Mast Therapeutics, Inc. Phase 1/Phase 2 2016-02-01 This study will assess the safety of inhaled sodium nitrite in adults with Cystic Fibrosis and chronic Pseudomonas infections, and determine the ability of sodium nitrite to reduce the burden of Pseudomonas.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for colistin sulfate

Condition Name

Condition Name for colistin sulfate
Intervention Trials
Cystic Fibrosis 1
Gram-Negative Bacterial Infections 1
Intestinal Colonization With Multidrug-resistant Bacteria 1
MIC 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for colistin sulfate
Intervention Trials
Communicable Diseases 2
Infections 2
Infection 2
Gram-Negative Bacterial Infections 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for colistin sulfate

Trials by Country

Trials by Country for colistin sulfate
Location Trials
France 1
Switzerland 1
Egypt 1
Netherlands 1
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for colistin sulfate
Location Trials
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for colistin sulfate

Clinical Trial Phase

Clinical Trial Phase for colistin sulfate
Clinical Trial Phase Trials
Phase 4 1
Phase 2 1
Phase 1/Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for colistin sulfate
Clinical Trial Phase Trials
Completed 2
Unknown status 1
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for colistin sulfate

Sponsor Name

Sponsor Name for colistin sulfate
Sponsor Trials
European Commission 1
Stephen Harbarth 1
DongGuk University 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for colistin sulfate
Sponsor Trials
Other 8
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Medtronic
Colorcon
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.